Literature DB >> 17626740

[Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma].

Long-Bo Gong1, Xue-Lai Luo, Shuang-You Liu, De-Ding Tao, Jian-Ping Gong, Jun-Bo Hu.   

Abstract

BACKGROUND &
OBJECTIVE: GRIM-19 (gene associated with retinoid-interferon-induced mortality-19) gene is a specific protein to inhibit signal transducers and activators of transcription 3 (STAT3). STAT3 and its pathway are involved in modulating cell proliferation, apoptosis, differentiation, and mediating malignant transformation of cells. This study was to investigate the expression of GRIM-19 and its target gene STAT3 in human colorectal carcinoma tissues, and explore their roles in the tumorigenesis of colorectal carcinoma.
METHODS: The expression of GRIM-19, STAT3 and its activated form p-STAT3 in 40 specimens of colorectal carcinoma, adjacent tissue, and normal tissue was determined by immunohistochemistry and Western blot. The correlations of the expression of GRIM-19, STAT3, and p-STAT3 to various clinicopathologic characteristics of colorectal carcinoma were analyzed statistically. The mRNA expression and gene mutation of GRIM-19 in colon cancer cell line SW480 and 23 specimens of colorectal carcinoma, adjacent tissue, and normal tissue were detected by reverse transcription-polymerase chain reaction (RT-PCR) and sequencing.
RESULTS: The expression of both STAT3 and p-STAT3 were up-regulated in colorectal carcinoma. The mRNA and protein expression of GRIM-19 was obviously lower in colorectal carcinoma than in normal tissues. The expression of GRIM-19 was correlated to clinical stage and cell differentiation of colorectal cancer (P< 0.05). GRIM-19 expression in colorectal cancer was negatively correlated to STAT3 and p-STAT3 expression (Chi2 = 9.95, P = 0.00; Chi2 = 5.10, P = 0.02). No mutation of GRIM-19 gene was detected in colorectal carcinoma tissues.
CONCLUSIONS: The low expression or absence of GRIM-19 may play an important role in the tumorigenesis of colorectal carcinoma. The high expression of STAT3 and the low expression of GRIM-19 co-exist in colorectal carcinoma, and may be related to malignant transformation and abnormal proliferation of cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626740

Source DB:  PubMed          Journal:  Ai Zheng


  14 in total

Review 1.  Genetic insights into OXPHOS defect and its role in cancer.

Authors:  Dhyan Chandra; Keshav K Singh
Journal:  Biochim Biophys Acta       Date:  2010-11-11

2.  Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Peng Sun; Yoshihiro Ohmori; Miki Hiroi; Kazumasa Mori; Daniel J Lindner; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2010-07-01       Impact factor: 4.307

Review 3.  Cytokine-induced tumor suppressors: a GRIM story.

Authors:  Dhan V Kalvakolanu; Shreeram C Nallar; Sudhakar Kalakonda
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

4.  Overexpression of GRIM-19, a mitochondrial respiratory chain complex I protein, suppresses hepatocellular carcinoma growth.

Authors:  Dexia Kong; Lijing Zhao; Yanwei Du; Ping He; Yabin Zou; Luoluo Yang; Liankun Sun; Hebin Wang; Deqi Xu; Xiangwei Meng; Xun Sun
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

5.  Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma.

Authors:  Feifei Li; Wanhua Ren; Yanda Zhao; Zhaoqing Fu; Yongjian Ji; Yuhua Zhu; Chengyong Qin
Journal:  Med Oncol       Date:  2012-04-11       Impact factor: 3.064

6.  Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Daniel J Lindner; Robert R Lorenz; Eric Lamarre; Xiao Weihua; Dhananjaya V Kalvakolanu
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

Review 7.  GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  Cytokine Growth Factor Rev       Date:  2016-09-15       Impact factor: 7.638

8.  Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in mice.

Authors:  Sudhakar Kalakonda; Shreeram C Nallar; Sausan Jaber; Susan K Keay; Ellen Rorke; Raghava Munivenkatappa; Daniel J Lindner; Gary M Fiskum; Dhananjaya V Kalvakolanu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

9.  Expression and clinical significance of GRIM-19 in lung cancer.

Authors:  Xiao-Yun Fan; Zi-Feng Jiang; Li Cai; Rong-Yu Liu
Journal:  Med Oncol       Date:  2012-05-10       Impact factor: 3.064

Review 10.  Inherited Thyroid Tumors With Oncocytic Change.

Authors:  Marcelo Correia; Ana Rita Lima; Rui Batista; Valdemar Máximo; Manuel Sobrinho-Simões
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-09       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.